| Literature DB >> 14871633 |
Evan J Anderson1, Stephen G Weber.
Abstract
Rotavirus has been recognised for 30 years as the most common cause of infectious gastroenteritis in infants and young children. By contrast, the role of rotavirus as a pathogen in adults has long been underappreciated. Spread by faecal-oral transmission, rotavirus infection in adults typically manifests with nausea, malaise, headache, abdominal cramping, diarrhoea, and fever. Infection can also be symptomless. Rotavirus infection in immunocompromised adults can have a variable course from symptomless to severe and sustained infection. Common epidemiological settings for rotavirus infection among adults include endemic disease, epidemic outbreak, travel-related infection, and disease resulting from child-to-adult transmission. Limited diagnostic and therapeutic alternatives are available for adults with suspected rotavirus infection. Because symptoms are generally self-limiting, supportive care is the rule. Clinicians caring for adults with gastroenteritis should consider rotavirus in the differential diagnosis. In this review we intend to familiarise clinicians who primarily provide care for adult patients with the salient features of rotavirus pathophysiology, clinical presentation, epidemiology, treatment, and prevention.Entities:
Mesh:
Substances:
Year: 2004 PMID: 14871633 PMCID: PMC7106507 DOI: 10.1016/S1473-3099(04)00928-4
Source DB: PubMed Journal: Lancet Infect Dis ISSN: 1473-3099 Impact factor: 25.071
FigureElectron micrographs of a human strain of rotavirus B. (A,B) Complete virus; (A,C) stages in the breakdown of virus particles as seen in preparations of stool samples (courtesy of Cornelia Buchen-Osmond, ICTVdB, the universal virus database of the International Committee on Taxonomy of Viruses).
Symptoms of adult volunteers after rotavirus ingestion
| Symptoms | Antibody response | Shed rotavirus | Diarrhoea | Vomiting | Headache | Anorexia | Malaise | Cramping or gas | Temperature >37·2°C | Chills | Nausea | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Middleton et al, 1974 (n=1) | 1 × 108 viral particles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Kapikian et al, 1983 (n=18) | 1 mL 0·2% stool filtrate | 22% | 67% | 28% | 22% | 11% | 22% | 22% | 17% | 11% | 17% | NR | NR |
| Ward et al, 1986 (n=36) | >9 ffu | 50% | 64% | 58% | 36% | 8% | 14% | NR | 17% | 17% | 19% | 11% | 22% |
| Ward et al, 1989 (n=38) | 9 × 101 to 9 × 103 ffu | 39% | 66% | 58% | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Ward et al 1990 (n=4) | 9 × 103 ffu | 25% | 75% | 50% | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| Summary percentages | ·· | 39% | 65% | 52% | 31% | 9% | 16% | 21% | 16% | 15% | 18% | 11% | 22% |
ffu=focus forming unit. NR=data not recorded in original paper and taken as not having occurred in calculation of summary percentages.
Data included when >50% infectious dose ingested (>9 ffu).
15 of 38 patients had mild illness (including one patient with no antibody response or shedding).
One of four volunteers experienced illness but no specific symptoms were recorded.
Summary percentages after rotavirus ingestion calculated only from data from studies in which full clinical syndrome of illness described. All percentages have been rounded to the nearest whole percentage point.